Related Experiment Video
Updated: May 9, 2026
12:28
Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
Published on: June 2, 2023
Tissue engineering techniques in cardiac repair and disease modelling
Christopher Rao, Hannah Barratt, Themistoklis Prodromakis
1Reader in Cardiac Electrophysiology, National Heart and Lung Institute, Imperial College London, 4th Floor Imperial Centre for Translational and Experimental Medicine, Hammersmith Campus, Du Cane Rd, London W12 0NN. c.terracciano@imperial.ac.uk.
Current Pharmaceutical Design
|July 13, 2013
Summary
Tissue engineering can improve cell therapy for heart failure by enhancing cell survival and retention. It also helps mature immature cardiomyocytes in vitro for better disease modeling.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cardiovascular Research
Background:
- Cell therapy shows promise for end-stage heart failure but faces challenges with poor cell survival and retention due to the harsh cardiac environment.
- The ischemic and inflamed environment of the failing heart can negatively impact the efficacy of transplanted cells.
- Immature cardiomyocytes require maturation for effective use in disease modeling.
Purpose of the Study:
- To explore how tissue engineering techniques can improve cell therapy for heart failure.
- To investigate the use of tissue engineering to enhance cell survival and retention in the cardiac environment.
- To discuss the application of tissue engineering in maturing cardiomyocytes and stem cells in vitro for disease modeling.
Main Methods:
- Review of key tissue engineering techniques and principles.
- Analysis of environmental modifications to support cell therapy.
- Discussion of in vitro cell culture methods for cardiomyocyte maturation.
Main Results:
- Tissue engineering offers strategies to overcome the hostile environment of the failing heart, improving cell therapy efficacy.
- Techniques exist to enhance cell survival and retention, crucial for successful cardiac repair.
- In vitro maturation of cardiomyocytes and stem cells is achievable through tissue engineering approaches.
Conclusions:
- Tissue engineering is a vital tool for advancing cell therapy in cardiovascular disease.
- Modifying the cellular microenvironment is key to successful cell transplantation.
- Tissue engineering facilitates the development of more accurate in vitro models for cardiac research.
